NCT01017146 A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301 Status COMPLETED Phase PHASE3
NCT01017120 A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne Status COMPLETED Phase PHASE3
NCT01016977 A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris Status COMPLETED Phase PHASE4
NCT01016444 Acute Asthma Responsiveness and B2 Adrenergic Receptors Polymorphisms Status COMPLETED Phase N/A
NCT01015638 Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications Status COMPLETED Phase PHASE4
NCT01015625 Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer Status COMPLETED Phase NA
NCT01014988 Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital Status COMPLETED Phase PHASE2
NCT01014962 A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail Fungus Status COMPLETED Phase PHASE1
NCT01014208 Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma Status COMPLETED Phase PHASE3
NCT01014091 Study to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in Children Status TERMINATED Phase PHASE3
NCT01013948 Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care Setting Status COMPLETED Phase N/A
NCT01013766 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics Status COMPLETED Phase PHASE1
NCT01013701 Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease Status TERMINATED Phase PHASE4
NCT01012362 Study of Pazopanib and Ixabepilone in Patients With Solid Tumors Status TERMINATED Phase PHASE1
NCT01010568 Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL) Status TERMINATED Phase PHASE2
NCT01010399 Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects Status COMPLETED Phase PHASE4
NCT01009814 Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1 Status COMPLETED Phase PHASE2